Technical Analysis for PETQ - PetIQ, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Up |
| See historical PETQ trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Apr 19 | 50 DMA Resistance | Bearish | 1.37% |
| Apr 19 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 1.37% |
| Apr 19 | Outside Day | Range Expansion | 1.37% |
| Apr 18 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.60% |
| Apr 18 | Narrow Range Bar | Range Contraction | -0.60% |
| Apr 18 | NR7 | Range Contraction | -0.60% |
| Apr 18 | Inside Day | Range Contraction | -0.60% |
| Apr 17 | 50 DMA Resistance | Bearish | -0.60% |
| Apr 17 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.60% |
| Apr 17 | Wide Bands | Range Expansion | -0.60% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-03-13
- Sector: Non-Cyclical Consumer Goods & Services
- Industry: Pet Food Manufacturing
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more PETQ news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 28.23 |
| 52 Week Low | 17.03 |
| Average Volume | 375,553 |
| 200-Day Moving Average | 0.0 |
| 50-Day Moving Average | 23.3799 |
| 20-Day Moving Average | 23.9183 |
| 10-Day Moving Average | 22.521 |
| Average True Range | 1.1378 |
| ADX | 24.79 |
| +DI | 19.87 |
| -DI | 26.14 |
| Chandelier Exit (Long, 3 ATRs ) | 24.3366 |
| Chandelier Exit (Short, 3 ATRs ) | 24.2534 |
| Upper Bollinger Band | 27.2092 |
| Lower Bollinger Band | 20.6274 |
| Percent B (%b) | 0.36 |
| BandWidth | 27.517842 |
| MACD Line | -0.3863 |
| MACD Signal Line | -0.2621 |
| MACD Histogram | -0.1243 |
| Fundamentals | Value |
|---|---|
| Market Cap | 304.26 Million |
| Num Shares | 13.2 Million |
| EPS | 0.50 |
| Price-to-Earnings (P/E) Ratio | 46.02 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 0.00 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 23.87 | ||||
| Resistance 3 (R3) | 23.81 | 23.48 | 23.72 | ||
| Resistance 2 (R2) | 23.48 | 23.26 | 23.50 | 23.67 | |
| Resistance 1 (R1) | 23.24 | 23.12 | 23.36 | 23.30 | 23.63 |
| Pivot Point | 22.91 | 22.91 | 22.97 | 22.93 | 22.91 |
| Support 1 (S1) | 22.67 | 22.69 | 22.79 | 22.73 | 22.39 |
| Support 2 (S2) | 22.34 | 22.55 | 22.36 | 22.35 | |
| Support 3 (S3) | 22.10 | 22.34 | 22.30 | ||
| Support 4 (S4) | 22.16 |
